uniQure Appoints New CEO, Elects Directors
Ticker: QURE · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1590560
| Field | Detail |
|---|---|
| Company | Uniqure N.V. (QURE) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors
TL;DR
uniQure gets a new CEO, Dr. Olav Hellebø, starting July 1st. Board changes too.
AI Summary
On June 18, 2024, uniQure N.V. announced the appointment of Dr. Olav Hellebø as Chief Executive Officer, effective July 1, 2024. Dr. Hellebø, who has been a member of uniQure's Supervisory Board since 2021, will succeed current CEO Matt Kapusta. The company also reported on the election of new directors and changes to its compensation committee.
Why It Matters
A change in CEO can signal a shift in company strategy or operational focus, potentially impacting future performance and investor outlook.
Risk Assessment
Risk Level: medium — CEO transitions can introduce uncertainty regarding future strategy and execution, impacting the company's trajectory.
Key Players & Entities
- uniQure N.V. (company) — Registrant
- Dr. Olav Hellebø (person) — Appointed Chief Executive Officer
- July 1, 2024 (date) — Effective date of new CEO
- Matt Kapusta (person) — Outgoing Chief Executive Officer
- 2021 (date) — Year Dr. Hellebø joined Supervisory Board
FAQ
Who is the new Chief Executive Officer of uniQure N.V.?
Dr. Olav Hellebø has been appointed as the new Chief Executive Officer of uniQure N.V.
When does the new CEO's appointment become effective?
The appointment of Dr. Olav Hellebø as CEO is effective July 1, 2024.
Who is Dr. Olav Hellebø succeeding?
Dr. Olav Hellebø will succeed current CEO Matt Kapusta.
What other significant changes were announced by uniQure N.V.?
uniQure N.V. also announced the election of new directors and changes to its compensation committee.
Since when has Dr. Olav Hellebø been associated with uniQure's Supervisory Board?
Dr. Olav Hellebø has been a member of uniQure's Supervisory Board since 2021.
Filing Stats: 1,131 words · 5 min read · ~4 pages · Grade level 10.9 · Accepted 2024-06-20 06:00:47
Filing Documents
- qure-20240618x8k.htm (8-K) — 81KB
- qure-20240618xex10d1.htm (EX-10.1) — 89KB
- 0001558370-24-009305.txt ( ) — 307KB
- qure-20240618.xsd (EX-101.SCH) — 3KB
- qure-20240618_lab.xml (EX-101.LAB) — 15KB
- qure-20240618_pre.xml (EX-101.PRE) — 10KB
- qure-20240618x8k_htm.xml (XML) — 5KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 18, 2024, the Company held its Annual Meeting. There were 48,549,437 ordinary shares entitled to vote or be voted. 32,728,406 ordinary shares were voted in person or by proxy at the Annual Meeting. The following are the voting results for the proposals considered and voted upon at the Annual Meeting, all of which are described in the Proxy Statement. Voting Proposal 1 - Resolution to adopt the 2023 Dutch statutory annual accounts and treatment of the results. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 22,675,506 2,254,845 1,130,221 6,667,834 Voting Proposal 2 - Resolution to discharge liability of the members of the Board. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 22,394,000 3,610,067 56,505 6,667,834 Voting Proposal 3 - Reappointment of Rachelle Jacques as non-executive director. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 20,325,426 5,720,419 14,727 6,667,834 Voting Proposal 4 - Reappointment of David Meek as non-executive director. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 18,774,743 7,274,773 11,056 6,667,834 Voting Proposal 5 - Resolution to authorize of the Board to issue ordinary shares and grant rights to subscribe for ordinary shares. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 21,556,588 4,483,234 20,750 6,667,834 Voting Proposal 6 - Resolution to authorize the Board to exclude or limit preemptive rights upon the issuance of ordinary shares and granting of rights to subscribe for ordinary shares. This proposal was approved as set forth below. For Against Abstain Broker Non-Votes 20,921,975 5,109,943 28,654 6,667,834 Voting Proposal 7 - Resolution to reauthorize the Board to repurchase ordinary shares. Th
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Amended and Restated 2014 Share Incentive Plan of uniQure N.V. (conformed to include the Second Amendment to the Amended and Restated 2014 Share Incentive Plan attached as Appendix A to the Proxy Statement) 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. UNIQURE N.V. Date: June 20, 2024 By: /s/ Jeannette Potts Jeannette Potts Chief Legal and Compliance Officer